RUNX1-ETO Leukemia
- PMID: 28299657
- DOI: 10.1007/978-981-10-3233-2_11
RUNX1-ETO Leukemia
Abstract
AML1-ETO leukemia is the most common cytogenetic subtype of acute myeloid leukemia, defined by the presence of t(8;21). Remarkable progress has been achieved in understanding the molecular pathogenesis of AML1-ETO leukemia. Proteomic surveies have shown that AML-ETO forms a stable complex with several transcription factors, including E proteins. Genome-wide transcriptome and ChIP-seq analyses have revealed the genes directly regulated by AML1-ETO, such as CEBPA. Several lines of evidence suggest that AML1-ETO suppresses endogenous DNA repair in cells to promote mutagenesis, which facilitates acquisition of cooperating secondary events. Furthermore, it has become increasingly apparent that a delicate balance of AML1-ETO and native AML1 is important to sustain the malignant cell phenotype. Translation of these findings into the clinical setting is just beginning.
Keywords: AML1(RUNX1); AML1-ETO (RUNX1-ETO); Acute myeloid leukemia; DNA repair; Epigenetics; Signal transduction; Transcription factor complex.
Similar articles
-
AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.FEBS J. 2014 Feb;281(4):1123-31. doi: 10.1111/febs.12673. Epub 2014 Jan 10. FEBS J. 2014. PMID: 24314118
-
AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.Oncogene. 2013 Apr 11;32(15):1978-87. doi: 10.1038/onc.2012.204. Epub 2012 May 28. Oncogene. 2013. PMID: 22641217
-
MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.Cell Rep. 2016 Jul 12;16(2):498-507. doi: 10.1016/j.celrep.2016.05.094. Epub 2016 Jun 23. Cell Rep. 2016. PMID: 27346355
-
Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.J Cell Physiol. 2009 Jul;220(1):16-20. doi: 10.1002/jcp.21769. J Cell Physiol. 2009. PMID: 19334039 Review.
-
Effects of the leukemia-associated AML1-ETO protein on hematopoietic stem and progenitor cells.Oncogene. 2004 May 24;23(24):4249-54. doi: 10.1038/sj.onc.1207673. Oncogene. 2004. PMID: 15156180 Review.
Cited by
-
1H, 13C, and 15N Backbone assignments of the human brain and acute leukemia cytoplasmic (BAALC) protein.Biomol NMR Assign. 2020 Oct;14(2):163-168. doi: 10.1007/s12104-020-09938-7. Epub 2020 Apr 2. Biomol NMR Assign. 2020. PMID: 32240523 Free PMC article.
-
RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.J Cell Biochem. 2018 Mar;119(3):2750-2762. doi: 10.1002/jcb.26443. Epub 2017 Nov 20. J Cell Biochem. 2018. PMID: 29052866 Free PMC article.
-
Clinical Implications of Inflammation in Acute Myeloid Leukemia.Front Oncol. 2021 Feb 22;11:623952. doi: 10.3389/fonc.2021.623952. eCollection 2021. Front Oncol. 2021. PMID: 33692956 Free PMC article. Review.
-
Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.DNA Cell Biol. 2020 Sep;39(9):1595-1605. doi: 10.1089/dna.2020.5667. Epub 2020 Aug 12. DNA Cell Biol. 2020. PMID: 32783661 Free PMC article.
-
Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia.Front Genet. 2022 Jul 22;13:923568. doi: 10.3389/fgene.2022.923568. eCollection 2022. Front Genet. 2022. PMID: 35938037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical